stockrow
Saturday 7 November 2026
Export AIDX’s income statement to Excel — free account
20/20 Biolabs Inc.
AIDX Healthcare Medical Devices
20/20 Biolabs Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 million, up 16.7% from fiscal 2024.
0.20
0.01
+5.26%
Follow AIDX
Alert me
| Dec '24 | Dec '25 | |
|---|---|---|
P/E ratio |
0.00 | 0.00 |
P/S ratio |
0.00 | 0.00 |
P/FCF ratio |
0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(35.48) | (33.18) |
Beneish M-Score |
— | (4.35) |
P/Operating CF |
(59.91) | (59.91) |
P/B ratio |
0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 |
EV/Operating CF |
(20.70) | (20.70) |
EV/FCF |
(20.70) | (20.70) |
Quick Ratio |
1.42 | 0.50 |
Current Ratio |
1.50 | 0.60 |
Net Debt/EBITDA |
0.32 | 0.11 |
Debt/Assets |
0.00% | 16.77% |
Debt/Equity |
0.00 | (36.15) |
Asset Turnover |
0.00 | 0.53 |
Operating CF/Net income |
0.47 | 0.51 |
Capex/Depreciation |
0.00 | 0.00 |
Interest Coverage |
(450.59) | (21.32) |
| 0.00% | (537.07%) | |
| 0.00% | (96.84%) | |
ROIC |
0.00% | 0.00% |
Return on Tangible Assets |
(697.63%) | 399.74% |
Average Days of Receivables |
28.18 | 35.70 |
Research and Development Expense of Revenue |
72.01% | 28.98% |
Selling, General and Administrative Expense of Revenue |
271.62% | 163.45% |
Intangible Assets out of Total Assets |
0.35 | 0.26 |
Share Based Compensation of Revenue |
124.19% | 25.24% |
Graham Net Nets |
(0.02) | (0.02) |
Graham Number |
0.00 | 0.00 |
Earnings Yield |
(158.71%) | (158.71%) |
Free Cash Flow Yield |
(4.82%) | (4.82%) |
Revenue per Share |
0.37 | 0.41 |
Operating CF per Share |
(0.54) | (0.39) |
Capex per Share |
0.00 | 0.00 |
Free Cash Flow per Share |
(0.54) | (0.39) |
Cash per Share |
0.37 | 0.21 |
Shareholders Equity per Share |
0.31 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
0.31 | 0.00 |
Free Cash Flow |
(2.60) | (1.92) |
Working Capital |
0.68 | (0.99) |
Net Current Asset Value |
(0.04) | (2.69) |
EV/EBIT |
0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 |
| Other line items | ||
Depreciation/Fixed assets |
1.21 | 3.41 |
Cash ROIC |
(79.00%) | (112.87%) |
Accounts Receivable Turnover |
0.00 | 12.20 |
Accounts Payable Turnover |
0.00 | 2.32 |
Inventory Turnover |
0.00 | 17.63 |
Average Days of Payables |
97.62 | 220.05 |
Days of Inventory on Hand |
12.38 | 29.44 |
Average Receivables |
— | 0.17 |
Average Payables |
— | 0.62 |
Average Inventory |
— | 0.08 |
Average Assets |
— | 3.86 |
Average Common Equity |
— | 0.70 |
Columns are period end dates